- Home
- EYPT vs PNNT Comparison
EYPT vs PNNT Comparison
Compare EYPT & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- PNNT
- Stock Information
- Founded
- EYPT 1987
- PNNT 2007
- Country
- EYPT United States
- PNNT United States
- Employees
- EYPT N/A
- PNNT N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- PNNT Finance: Consumer Services
- Sector
- EYPT Industrials
- PNNT Finance
- Exchange
- EYPT Nasdaq
- PNNT Nasdaq
- Market Cap
- EYPT 484.4M
- PNNT 442.7M
- IPO Year
- EYPT 2005
- PNNT 2007
- Fundamental
- Price
- EYPT $10.37
- PNNT $6.78
- Analyst Decision
- EYPT Strong Buy
- PNNT Sell
- Analyst Count
- EYPT 8
- PNNT 3
- Target Price
- EYPT $24.75
- PNNT $5.88
- AVG Volume (30 Days)
- EYPT 817.0K
- PNNT 347.1K
- Earning Date
- EYPT 08-06-2025
- PNNT 08-06-2025
- Dividend Yield
- EYPT N/A
- PNNT 14.15%
- EPS Growth
- EYPT N/A
- PNNT N/A
- EPS
- EYPT N/A
- PNNT 0.73
- Revenue
- EYPT $56,042,000.00
- PNNT $138,371,000.00
- Revenue This Year
- EYPT N/A
- PNNT N/A
- Revenue Next Year
- EYPT N/A
- PNNT N/A
- P/E Ratio
- EYPT N/A
- PNNT $9.30
- Revenue Growth
- EYPT 12.04
- PNNT N/A
- 52 Week Low
- EYPT $3.91
- PNNT $5.72
- 52 Week High
- EYPT $13.99
- PNNT $8.04
- Technical
- Relative Strength Index (RSI)
- EYPT 72.76
- PNNT 53.53
- Support Level
- EYPT $7.94
- PNNT $6.59
- Resistance Level
- EYPT $10.77
- PNNT $6.78
- Average True Range (ATR)
- EYPT 0.74
- PNNT 0.12
- MACD
- EYPT 0.10
- PNNT -0.01
- Stochastic Oscillator
- EYPT 85.87
- PNNT 46.00
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.